Exchange: NASDAQ·Updated 04:05 AM EDT
Latest Earnings Results: Q2 '26

Reported: Aug 07

Estimated EPS

-$0.24

Reported EPS

-$0.27

Surprise

-10.96%

Estimated Rev

$7.88M

Reported Rev

$8.05M

Surprise

+2.27%

• Reported GAAP EPS of -$0.27 • Reported revenue of $8.05M up 10.91% YoY • Rapid Micro Biosystems is reaffirming its full year 2026 total revenue guidance range of $37.0 million to $41.0 million, including 30 to 38 Growth Direct system placements and gross margins of 20%.

Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

10-Q

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '26
-$0.20
--
--
N/A
Q2 '26
-$0.24
-$0.27
-10.96%
MISSED
Q1 '26
-$0.25
-$0.31
-25.68%
MISSED
Q4 '25
-$0.23
-$0.28
-23.53%
MISSED
Q3 '25
-$0.25
-$0.26
-6.12%
MISSED

Advertisement|Remove ads.